Form 4: Aura Biosciences VP of Finance Sells Shares to Cover Tax Obligations

Amy Elazzouzi, Vice President of Finance at Aura Biosciences, sold 553 shares of common stock on October 29, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On October 29, 2024, Amy Elazzouzi, the Vice President of Finance at Aura Biosciences, sold 553 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $10.7385, with individual transactions ranging from $10.65 to $10.74.
• Following the transaction, Elazzouzi directly owns 39,443 shares of Aura Biosciences.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's confidence in the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. This provides transparency to the market.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders as it is a small transaction related to tax obligations.

Key Dates